Evidence map›Paper›PMID 35670091›Full record

ArticleJournal of enzyme inhibition and medicinal chemistry2022

Design and biological evaluation of substituted 5,7-dihydro-6

Sreenivas Avula, Xudan Peng, Xingfen Lang, Micky Tortorella, Béatrice Josselin, Stéphane Bach, Stephane Bourg, Pascal Bonnet, Frédéric Buron, Sandrine Ruchaud and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of enzyme inhibition and medicinal chemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Syntheses of 3-(2-Nitrovinyl)-indoles, Benzo[The Journal of organic chemistry · 2024
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Sreenivas AvulaGuangzhou Institute of Biomedicine and Health, Chinese Academy of Science, Guangzhou, China.
Xudan PengGuangzhou Institute of Biomedicine and Health, Chinese Academy of Science, Guangzhou, China.
Xingfen LangGuangzhou Institute of Biomedicine and Health, Chinese Academy of Science, Guangzhou, China.
Micky TortorellaGuangzhou Institute of Biomedicine and Health, Chinese Academy of Science, Guangzhou, China.
Béatrice JosselinSorbonne Université/CNRS UMR8227, Roscoff cedex, France.
Stéphane BachSorbonne Université/CNRS UMR8227, Roscoff cedex, France.
Stephane BourgInstitut de Chimie Organique et Analytique, Université d'Orléans, UMR CNRS 7311, Orleans, France.
Pascal BonnetInstitut de Chimie Organique et Analytique, Université d'Orléans, UMR CNRS 7311, Orleans, France.
Frédéric BuronInstitut de Chimie Organique et Analytique, Université d'Orléans, UMR CNRS 7311, Orleans, France.
Sandrine RuchaudSorbonne Université/CNRS UMR8227, Roscoff cedex, France.
Sylvain RoutierInstitut de Chimie Organique et Analytique, Université d'Orléans, UMR CNRS 7311, Orleans, France.
Cleopatra NeagoieGuangzhou Institute of Biomedicine and Health, Chinese Academy of Science, Guangzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A library of substituted indolo[2,3-

Indexed as

Bone NeoplasmsQuinolonesHumansProtein Kinase InhibitorsProtein Serine-Threonine KinasesStructure-Activity RelationshipProtein Kinase InhibitorsProtein Serine-Threonine KinasesQuinolonescell viabilitydockingHaspin kinaseIndoloquinoline

Identifiers

PMID35670091
PMCPMC9186362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.